Paper - WANFANG MED ONLINE

You Position: Home > Paper

Role of intestinal microbiota in pathogenesis of inflammatory bowel disease

( views:29, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 33

DOI:: 10.11569/wcjd.v24.i33.4505

Key Word:: 肠道菌群;炎症性肠病;微生态制剂;肠道菌群移植;Inflammatory bowel disease;Intestinal microbiota;Microbial ecological agent;Fecal microbiota transplantation

Abstract：炎症性肠病(inflammatory bowel disease,IBD)是一种慢性反复发作的肠道炎症性疾病,其发病机制尚不明确.肠道菌群已被证实对肠道免疫系统的发育和激活具有重要作用,肠道菌群变化可能诱发或加重IBD,而调节肠道菌群对治疗IBD具有一定的积极作用,本文就目前肠道菌群与IBD之间关系的研究进展作一综述.

Reference

[1]白爱平.炎症性肠病发病机制的微生物因素[J].2006,(7).
[2]牛敏,邵天波,陈瑞春,等.溃疡性结肠炎患者肠道菌群分析和细菌毒素基因检测?[J].2015,(4).
[3]张静,韩英,王继恒.炎症性肠病与肠道细菌研究进展[J].2007,(12).
[4]梁淑文,王晓英,屈昌民,等.溃疡性结肠炎患者肠道菌群变化的临床研究[J].2015,(9).
[5]张婷,陈烨,王中秋,等.炎症性肠病患者肠道菌群结构的变化及其与炎性指标的关系[J].2013,(10).
[6]翟华珍,周有连.炎症性肠病患者肠道菌群变化及其与炎性指标的关系[J].2014,(21).
[7]谭蓓,钱家鸣.炎症性肠病与肠道菌群[J].2015,(5).
[8]Baldassano RN,Giannetti E,Miele E,etc.Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.[J].2009,104(2).
[9].Rifaximin in the treatment of recurrent Clostridium difficile infection[J].2013,37(1).
[10]Rajca, Sylvie,Grondin, Virginie,Louis, Edouard,etc.Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohn's Disease[J].2014,20(6).
[11]Julio, Gálvez.Role of Th17 Cells in the Pathogenesis of Human IBD.[J].2014,2014.
[12]Catherine Juste,David P Kreil,Christian Beauvallet,etc.Bacterial protein signals are associated with Crohn's disease[J].2014,63(10).
[13]Savoye G,Dacher JN,Koning E,etc.Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.[J].2011,17(8).
[14]Colman, Ruben J.,Rubin, David T..Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis[J].2014,8(12).
[15]Lee, Dale,Albenberg, Lindsey,Compher, Charlene,etc.Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases[J].2015,148(6).
[16]Ryma, Toumi,Katia, Abdelouhab,Hayet, Rafa,etc.Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.[J].2013,35(3).
[17]Sekhon, Bhupinder Singh,Jairath, Saloni.Prebiotics, probiotics and synbiotics: an overview.[J].2010,1(2).
[18]Strober W.Inside the microbial and immune labyrinth: Gut microbes: friends or fiends?[J].2010,16(11).
[19]宋军民,杨超,常远,等.炎症性肠病患者肠道菌群变化与发病关系研究[J].2015,(15).
[20]Rachmilewitz D,Dotan I.Probiotics in inflammatory bowel disease: possible mechanisms of action.[J].2005,21(4).
[21]Andrew S. Day.Inflammatory Bowel Disease and the Intestinal Microbiota[J].2015,5(2).
[22]J D, Taurog,J A, Richardson,J T, Croft,etc.The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.[J].1994,180.
[23]R K, Sellon,S, Tonkonogy,M, Schultz,etc.Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.[J].1998,66.
[24]Khoruts A,Dicksved J,Jansson JK,etc.Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.[J].2010,44(5).
[25]Daisy, Batista,Laura, Raffals.Role of intestinal bacteria in the pathogenesis of pouchitis.[J].2014,20.
[26]Yi-Zhen Zhang,Yong-Yu Li.Inflammatory bowel disease:Pathogenesis[J].2014,(1).
[27]Komanduri S,Gillevet PM,Sikaroodi M,etc.Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation.[J].2007,5(3).
[28]BEN P. WILLING,JOHAN DICKSVED,JONAS HALFVARSON,etc.A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes[J].2010,139(6).
[29]Barbara Poniedzia?ek,Piotr Rzymski,Jacek Karczewski.Increased apoptosis of regulatory T cells in Crohn's disease.[J].2014,61(130).
[30]钟世顺,李淑梅,张振书.双歧杆菌黏附素对大鼠肠缺血再灌注损伤后肠道菌群和细菌易位的影响[J].2014,0(24).
[31]Els van Nood,Anne Vrieze,Max Nieuwdorp,etc.Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile[J].2013,368(5).
[32]Nakanishi, Y.,Sato, T.,Ohteki, T..Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization[J].2015,8(1).
[33]Gevers, Dirk,Kugathasan, Subra,Denson, Lee A.,etc.The Treatment-Naive Microbiome in New-Onset Crohn's Disease[J].2014,15(3).
[34]Morgan XC,Tickle TL,Sokol H,etc.Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.[J].2012,13(9).
[35]Anderson,J.L.,Edney,R.J.,Whelan,K..Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease[J].2012,36(6).
[36]Griffiths,A.M.,Wine,E.,Mack,D.R.,etc.Alterations in the gut microbiome of children with severe ulcerative colitis[J].2012,18(10).
[37]Kale-Pradhan,P.B.,Zhao,J.J.,Wilhelm,S.M.,etc.The role of antimicrobials in Crohn's disease[J].2013,7(3).
[38]Wlodarska, Marta,Kostic, Aleksandar D.,Xavier, Ramnik J..An Integrative View of Microbiome-Host Interactions in Inflammatory Bowel Diseases[J].2015,17(5).
[39]Shaikh H,Gough E,Manges AR.Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.[J].2011,53(10).
[40]Tyler, Andrea D.,Knox, Natalie,Kabakchiev, Boyko,etc.Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis.[J].2013,8(9).
[41]Frank DN,Robertson CE,Hamm CM,etc.Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.[J].2011,17(1).
[42]Kostic,A.D.,Xavier,R.J.,Gevers,D..The microbiome in inflammatory bowel disease: Current status and the future ahead[J].2014,146(6).
[43]De Cruz, Peter,Kang, Seungha,Wagner, Josef,etc.Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study[J].2015,30(2).
[44]Cong Y,Elson CO,Feng T.Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota.[J].2011,11(5).
[45]Serriari,N.-E.,Eoche,M.,Lamotte,L.,etc.Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases[J].2014,176(2).